COVID-19: How to Stay Connected

Learn More
Refine Results




Advocacy

  • Comments to CBP Regarding Its Proposal to Amend 19 CFR Parts 133 and 151

    June 25, 2012 Mr. David V. Aguilar Acting Commissioner, U.S. Customs and Border Protection Trade and Commercial Regulations Branch Office of International Trade, Regulations and Rulings U.S. Customs and Border Protection 799 9th Street NW. (Mint Annex) Washington, DC 20229-1179 Re: Docket No. USCBP 20120011: Notice of Proposed Rulemaking Disclosure of Information for Certain Int

    Categories: Letter, Legislation, Customs and Border Protection

  • AIPLA Comments on FDA Biosimilars Draft Guidances

    May 24, 2012 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA2011-D-0605: Draft Guidance for Industry on Scientific Considerations in Demonstrating Biosimilarity to a Reference Product Docket No. FDA2011-D-0602: Draft Guidance for Industry on Quality Considerations in Demonstrating Biosimilarity to

    Categories: Letter, Food and Drug Administration, Executive

  • AIPLA Comments on Remedies for Small Copyright Claims

    _ January 16, 2012 Ms. Maria A. Pallante Register of Copyrights U.S. Copyright Office 101 Independence Avenue, SE Washington, DC 20559-6000 Re: Comments Submitted Pursuant to Notice of Inquiry Regarding Remedies for Small Copyright Claims, 76 Fed. Reg. 66,758 (Oct. 27, 2011) Dear Register Pallante: The American Intellectual Property Law Association (AIPLA) is pleased to

    Categories: Letter, Executive, Copyright

  • AIPLA Comments on Standards-Setting Issues In Connection with Patent Standards Workshop

    _ June 14, 2011 Mr. Donald S. Clark Secretary Federal Trade Commission Office of Secretary Room HB113 (Annex X) 600 Pennsylvania Avenue, NW Washington, DC 20580 Re: Patent Standards Workshop, Project No. P11 1204 Dear Secretary Clark: The American Intellectual Property Law Association (AIPLA) submits these comments in response to the request of the Federal Trade Commissio

    Categories: Federal Trade Commission, Executive, Comments

  • AIPLA Comments to DMCA Rulemaking Regarding Exemptions to Prohibition on Circumvention of Copyright Protection Systems for Access Control Technologies

    Microsoft Word - Copyright Office General Counsel _3_ 020209.doc 241 18th Street, Suite 700, Arlington, VA 22202 Phone: 703-415-0780 Fax: 703-415-0786 www.aipla.org February 2, 2009 Office of the General Counsel U.S. Copyright Office James Madison Memorial Building Room LM 401 101 Independence Avenue, SE. Washington, DC 20559-6000 Re: Docket No. RM 2008-8 Reply Comm

    Categories: Letter, Executive, Copyright

  • AIPLA Comments re FDA Implementation of the Q1 Act

    Microsoft Word - Final - Comments re FDA Implementation of QI Act _2_.doc 241 18th Street, Suite 700, Arlington, VA 22202 Phone: 703-415-0780 Fax: 703-415-0786 www.aipla.org January 30, 2009 Division of Dockets Management Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane, Room 1061 Rockville, MD 20852 RE: FDA-2008-D-0609 - Draft Guid

    Categories: Letter, Food and Drug Administration, Executive

  • AIPLA Comments on Section 5 Workshop

    October 24, 2008 Richard C. Donohue Acting Secretary Federal Trade Commission Office of the Secretary Room H-135 (Annex C) 600 Pennsylvania Avenue, N.W. Washington, DC 20580 Re: Section 5 Workshop -- Comment, Project No. P083900 Dear Mr. Donohue: The American Intellectual Property Association (AIPLA) submits these comments in response to the request of the Federal Trade Commission

    Categories: Federal Trade Commission, Executive, Comments

  • AIPLA Response to the Decision and Proposed Consent Order in the N-Data proceeding

    Microsoft Word - AIPLA Ltr to FTC re N-Data.doc AIPLA AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION 241 18th Street, South, Suite 700, Arlington, VA 22202 Phone: 703.415.0780 Fax: 703.415.0786 www.aipla.org April 5, 2008 Donald S. Clark Secretary Federal Trade Commission Office of Secretary 600 Pennsylvania Avenue, NW Washington, DC 20580 Re: In the Matter of Negotiat

    Categories: Federal Trade Commission, Executive, Comments

  • Comments Submitted Pursuant to Notice of Inquiry to Examine Issues Raised by “Orphan Works”

    Microsoft Word - OrphanWorks.DOC May 8, 2005 Jule L. Sigall Associate Register for Policy and International Affairs U.S. Copyright Office James Madison Memorial Building, Room LM-401 101 Independence Ave., S.E. Washington, DC 20540 Reply Comments to Comments Submitted Pursuant to Notice of Inquiry to Examine Issues Raised by Orphan Works 70 Federal Register 3739 (Jan

    Categories: Comments, Executive, Copyright

  • AIPLA Response to the Antitrust Modernization Commission Regarding Questions for Public Comment on Its New Economy Study Plan

    Microsoft Word - AntitrustModernizationResponse.doc 1 AIPLA Response to the Antitrust Modernization Commission Questions for Public Comment New Economy Issues The Antitrust Modernization Commission has requested public comment on several questions relating to its New Economy Study Plan. AIPLA submits this comment in response to two of those questions: (1) What significa

    Categories: Letter, Executive, Department of Justice